- Country: United Kingdom
- Summary: Investigational Medicinial Product (Imp) and Placebo Manufacture - Im Woman Trial
- GBT Ref No: 60234659
- Deadline: 05 Jan 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: LSHTM-2021-29
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Investigational Medicinial Product (IMP) and Placebo Manufacture - IM Woman Trial
Process :-Open Process (Single Stage)
CPV codes :-33600000-6 Pharmaceutical products
33698000-9 Clinical products
44617100-9 Cartons
33141310-6 Syringes
33621000-9 Medicinal products for the blood and blood-forming organs
33621200-1 Antihaemorrhagics
39299100-5 Glass ampoules
33141320-9 Medical needles
79920000-9 Packaging and related services
Countries : United Kingdom
Last Date of Submission : 05/01/2022 13:00:00 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINInvestigational Medicinial Product (Imp) and Placebo Manufacture - Im Woman Trial - Uk Tender
The LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE, a Government sector organization in United Kingdom, has announced a new tender for Investigational Medicinial Product (Imp) and Placebo Manufacture - Im Woman Trial. This tender is published on UkTender under GBT Ref No: 60234659 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-01-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
